239 related articles for article (PubMed ID: 22648734)
1. Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat.
Ahmad A; Khan MM; Javed H; Raza SS; Ishrat T; Khan MB; Safhi MM; Islam F
Mol Cell Biochem; 2012 Aug; 367(1-2):215-25. PubMed ID: 22648734
[TBL] [Abstract][Full Text] [Related]
2. Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: Biochemical and ultrastructural evidence.
Hassan MQ; Akhtar MS; Akhtar M; Ali J; Haque SE; Najmi AK
Redox Rep; 2015; 20(6):275-81. PubMed ID: 25893851
[TBL] [Abstract][Full Text] [Related]
3. Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion.
Ahmad A; Khan MM; Hoda MN; Raza SS; Khan MB; Javed H; Ishrat T; Ashafaq M; Ahmad ME; Safhi MM; Islam F
Neurochem Res; 2011 Aug; 36(8):1360-71. PubMed ID: 21472457
[TBL] [Abstract][Full Text] [Related]
4. A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.
Fujiwara N; Som AT; Pham LD; Lee BJ; Mandeville ET; Lo EH; Arai K
Neurosci Lett; 2016 Oct; 633():7-13. PubMed ID: 27589890
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antioxidant and neuroprotective effect of ethanolic extract of Embelia ribes Burm in focal cerebral ischemia/reperfusion-induced oxidative stress in rats.
Nazam Ansari M; Bhandari U; Islam F; Tripathi CD
Fundam Clin Pharmacol; 2008 Jun; 22(3):305-14. PubMed ID: 18485149
[TBL] [Abstract][Full Text] [Related]
6. Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats.
Khan MM; Ishrat T; Ahmad A; Hoda MN; Khan MB; Khuwaja G; Srivastava P; Raza SS; Islam F; Ahmad S
Chem Biol Interact; 2010 Jan; 183(1):255-63. PubMed ID: 19835851
[TBL] [Abstract][Full Text] [Related]
7. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
[TBL] [Abstract][Full Text] [Related]
8. Combination drug therapy using edaravone and Daio-Orengedoku-to after transient focal ischemia in rats.
Cho KH; Oh JK; Jang YS; Jung JW; Oh HR; Park EK; Kim DH; Moon SK; Kim DH; Ryu JH
Methods Find Exp Clin Pharmacol; 2008; 30(6):443-50. PubMed ID: 18850045
[TBL] [Abstract][Full Text] [Related]
9. Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damage.
Hassan MQ; Akhtar MS; Akhtar M; Ali J; Haque SE; Najmi AK
Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):214-23. PubMed ID: 26868288
[TBL] [Abstract][Full Text] [Related]
10. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke.
Raza SS; Khan MM; Ahmad A; Ashafaq M; Khuwaja G; Tabassum R; Javed H; Siddiqui MS; Safhi MM; Islam F
Brain Res; 2011 Oct; 1420():93-105. PubMed ID: 21959178
[TBL] [Abstract][Full Text] [Related]
11. Rutin protects the neural damage induced by transient focal ischemia in rats.
Khan MM; Ahmad A; Ishrat T; Khuwaja G; Srivastawa P; Khan MB; Raza SS; Javed H; Vaibhav K; Khan A; Islam F
Brain Res; 2009 Oct; 1292():123-35. PubMed ID: 19631195
[TBL] [Abstract][Full Text] [Related]
12. In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice.
Liu N; Shang J; Tian F; Nishi H; Abe K
Brain Res; 2011 Jun; 1397():66-75. PubMed ID: 21571257
[TBL] [Abstract][Full Text] [Related]
13. A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.
Chiazza F; Chegaev K; Rogazzo M; Cutrin JC; Benetti E; Lazzarato L; Fruttero R; Collino M
Oxid Med Cell Longev; 2015; 2015():804659. PubMed ID: 25834700
[TBL] [Abstract][Full Text] [Related]
14. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
15. Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat.
Nakashima M; Niwa M; Iwai T; Uematsu T
Free Radic Biol Med; 1999 Mar; 26(5-6):722-9. PubMed ID: 10218662
[TBL] [Abstract][Full Text] [Related]
16. Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion.
Yamamoto Y; Yanagisawa M; Tak NW; Watanabe K; Takahashi C; Fujisawa A; Kashiba M; Tanaka M
Redox Rep; 2009; 14(6):251-8. PubMed ID: 20003710
[TBL] [Abstract][Full Text] [Related]
17. Edaravone offers neuroprotection in a diabetic stroke model via inhibition of endoplasmic reticulum stress.
Srinivasan K; Sharma SS
Basic Clin Pharmacol Toxicol; 2012 Feb; 110(2):133-40. PubMed ID: 21752197
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia.
Shichinohe H; Kuroda S; Yasuda H; Ishikawa T; Iwai M; Horiuchi M; Iwasaki Y
Brain Res; 2004 Dec; 1029(2):200-6. PubMed ID: 15542075
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of stroke.
Dohare P; Hyzinski-García MC; Vipani A; Bowens NH; Nalwalk JW; Feustel PJ; Keller RW; Jourd'heuil D; Mongin AA
Free Radic Biol Med; 2014 Dec; 77():168-82. PubMed ID: 25224033
[TBL] [Abstract][Full Text] [Related]
20. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
